We are live on
!
Find out more
AC
Almitas Capital Portfolio holdings
AUM
$417M
1-Year Est. Return
22.81%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+22.81%
3 Year Est. Return
+86.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$443M
AUM Growth
-$11.6M
(-2.6%)
Cap. Flow
+$39.4M
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
57.81%
Holding
137
New
31
Increased
31
Reduced
16
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASA
ASA Gold and Precious Metals
ASA
|
+$9.69M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$8.71M |
| 3 |
NQP
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
|
+$8.22M |
| 4 |
PDX
PIMCO Dynamic Income Strategy Fund
PDX
|
+$7.91M |
| 5 |
CRF
Cornerstone Total Return Fund
CRF
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FETH
Fidelity Ethereum Fund
FETH
|
+$19.2M |
| 2 |
FSSL
FS Specialty Lending Fund
FSSL
|
+$6.95M |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$4.92M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$4.84M |
| 5 |
ARR
Armour Residential REIT
ARR
|
+$3.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 65.84% |
| 2 | Healthcare | 19.22% |
| 3 | Financials | 5.65% |
| 4 | Real Estate | 4.84% |
| 5 | Consumer Discretionary | 2.1% |
Similar funds
CWA
SCM
EWM
RA
MWM
VA
CWM
LWMNY
Almitas Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Almitas Capital held 137 positions worth $443M, down 2.6% from $454M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Almitas Capital deployed $39.4M of net new capital in Q1 2026, opening 31 new positions and adding to 31 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 30,254 shares worth $8.43M.
By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, up from 64% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was FS Specialty Lending Fund, an estimated $6.95M trimmed.
- Almitas Capital's largest Q1 2026 buy was Bio-Rad Laboratories Class A: 30,254 shares worth $8.43M.
- Almitas Capital added most to ASA Gold and Precious Metals in Q1 2026, an estimated $9.69M increase.
- Almitas Capital's biggest Q1 2026 reduction was FS Specialty Lending Fund, cutting an estimated $6.95M.
- Almitas Capital fully exited Fidelity Ethereum Fund in Q1 2026, selling an estimated $19.2M.
- Almitas Capital's ten largest holdings make up 58% of its $443M portfolio in Q1 2026.
- Almitas Capital opened 31 new positions and closed 22 in Q1 2026.
- Almitas Capital's portfolio value fell 2.6% quarter-over-quarter to $443M.
Based on Almitas Capital's 13F filing for Q1 2026, filed 15 May 2026.